Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « Auteurs » - entrée « J. Heitman »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J. Harper < J. Heitman < J. Hernández-Losa  Facettes :

List of bibliographic references indexed by J. Heitman

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
001996 (2001) N S Cutler [États-Unis] ; X. Pan ; J. Heitman ; M E CardenasThe TOR signal transduction cascade controls cellular differentiation in response to nutrients.
001997 (2001) J. Rohde [États-Unis] ; J. Heitman ; M E CardenasThe TOR kinases link nutrient sensing to cell growth.
001A06 (2001) M C Cruz [États-Unis] ; A L Goldstein ; J. Blankenship ; M. Del Poeta ; J R Perfect ; J H Mccusker ; Y L Bennani ; M E Cardenas ; J. HeitmanRapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.
001A47 (1999) M E Cardenas [États-Unis] ; N S Cutler ; M C Lorenz ; C J Di Como ; J. HeitmanThe TOR signaling cascade regulates gene expression in response to nutrients.
001A49 (1999) N S Cutler [États-Unis] ; J. Heitman ; M E CardenasTOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals.
001A54 (1999) M C Cruz [États-Unis] ; L M Cavallo ; J M Görlach ; G. Cox ; J R Perfect ; M E Cardenas ; J. HeitmanRapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.
001A55 (1999) C M Alarcon [États-Unis] ; J. Heitman ; M E CardenasProtein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
001A57 (1999) K J Dolinski [États-Unis] ; J. HeitmanHmo1p, a high mobility group 1/2 homolog, genetically and physically interacts with the yeast FKBP12 prolyl isomerase.
001A60 (1999) M E Cardenas [États-Unis] ; M C Cruz ; M. Del Poeta ; N. Chung ; J R Perfect ; J. HeitmanAntifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.
001A70 (1998) M E Cardenas [États-Unis] ; A. Sanfridson ; N S Cutler ; J. HeitmanSignal-transduction cascades as targets for therapeutic intervention by natural products.
001A72 (1998) D. Zaragoza [Canada] ; A. Ghavidel ; J. Heitman ; M C SchultzRapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway.
001A87 (1997) C M Alarc N [États-Unis] ; J. HeitmanFKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae.
001A91 (1997) A. Odom [États-Unis] ; S. Muir ; E. Lim ; D L Toffaletti ; J. Perfect ; J. HeitmanCalcineurin is required for virulence of Cryptococcus neoformans.
001A92 (1997) K. Dolinski [États-Unis] ; S. Muir ; M. Cardenas ; J. HeitmanAll cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae.
001A98 (1996) C M Alarcon [États-Unis] ; M E Cardenas ; J. HeitmanMammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
001B01 (1996) C S Hemenway [États-Unis] ; J. HeitmanImmunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast.
001B10 (1995) M C Lorenz [États-Unis] ; J. HeitmanTOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
001B19 (1995) M E Cardenas [États-Unis] ; J. HeitmanFKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
001B35 (1993) J. Heitman [Suisse] ; A. Koller ; J. Kunz ; R. Henriquez ; A. Schmidt ; N R Movva ; M N HallThe immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae.
001B47 (1992) J. Heitman [Suisse] ; N R Movva ; M N HallProline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression.
001B54 (1991) J. Heitman [Suisse] ; N R Movva ; M N HallTargets for cell cycle arrest by the immunosuppressant rapamycin in yeast.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "J. Heitman" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "J. Heitman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    J. Heitman
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020